PD-1 Blockade Cellular Vesicles for Cancer Immunotherapy

Author:

Zhang Xudong12,Wang Chao1,Wang Jinqiang1,Hu Quanyin1,Langworthy Benjamin3,Ye Yanqi1,Sun Wujin1,Lin Jing2,Wang Tianfu2,Fine Jason3,Cheng Hao4,Dotti Gianpietro5,Huang Peng2,Gu Zhen16

Affiliation:

1. Joint Department of Biomedical Engineering; University of North Carolina at Chapel Hill and North Carolina State University; Raleigh NC 27695 USA

2. Guangdong Key Laboratory for Biomedical Measurements and Ultrasound Imaging; School of Biomedical Engineering; Health Science Center; Shenzhen University; Shenzhen 518060 China

3. Department of Biostatistics; University of North Carolina at Chapel Hill; Chapel Hill NC 27599 USA

4. Department of Materials Science and Engineering; Drexel University; Philadelphia PA 19104 USA

5. Department of Microbiology and Immunology; School of Medicine; University of North Carolina at Chapel Hill; Chapel Hill NC 27599 USA

6. Department of Medicine; University of North Carolina School of Medicine; Chapel Hill NC 27599 USA

Funder

Alfred P. Sloan Foundation

North Carolina Translational and Clinical Sciences Institute, University of North Carolina at Chapel Hill

National Institutes of Health

University of North Carolina

National Natural Science Foundation of China

Basic Research Program of Shenzhen

Fok Ying Tong Education Foundation

China Postdoctoral Science Foundation

Publisher

Wiley

Subject

Mechanical Engineering,Mechanics of Materials,General Materials Science

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3